News
-
-
PRESS RELEASE
CORRECTION: Alphinat annonce une benifice nette de 803 $ pour la trimestre financier terminé le 28 février 2024
Alphinat Inc. corrects a date reference and a contact name in the press release published on November 8, 2024, showcasing financial results and strategic solutions for growth -
PRESS RELEASE
The Tandem Meetings of ASTCT and CIBMTR Return to Hawai'i From February 12-15, 2025
ASTCT and CIBMTR unite leading experts at the Tandem Meetings to share advancements in HCT, cellular therapy, and gene therapy with a global community of professionals. Event highlights latest scientific updates and innovative technologies -
-
-
-
PRESS RELEASE
Kudelski IoT Launches Quantum-Resistant Security IP, Future-Proofing Semiconductors Against Emerging Quantum Threats
Kudelski IoT integrates quantum-resistant security IP into KSE products to protect semiconductors from emerging quantum threats. Enhancing long-term data protection for devices -
PRESS RELEASE
Formycon extends Management Board contract for CEO Dr. Stefan Glombitza until 2027 and receives admission to trading in the Prime Standard
Formycon extends CEO contract until 2027. Receives admission to trading in Frankfurt Stock Exchange's Prime Standard. Company's biosimilars contribute to healthcare accessibility and cost reduction -
-
